Acute Coronary Syndrome
IMMEDIATE: Early Use of Inexpensive Glucose-Insulin- Potassium Solution Can Prevent Cardiac Arrest in ACS
Glucose-insulin-potassium (GIK) solution, given by paramedics very early after symptom onset in patients with an acute coronary syndrome (ACS), can reduce the risk for cardiac arrest or death by 50% during the first 30 days after the ACS event, according to results of a new study presented at the 2012 American College of Cardiology meeting.
Chicago, IL—The new oral anticoagulants rivaroxaban (Xarelto), dabigatran (Pradaxa), and the yet-to-be-approved apixaban (Eliquis) have been shown to be superior to warfarin (Coumadin) in preventing stroke in patients with atrial fibrillation (AF).
Results 1 - 2 of 2